<DOC>
	<DOCNO>NCT00947011</DOCNO>
	<brief_summary>This research do evaluate effect glucagon-like peptide-1 ( GLP-1 , naturally occur hormone ) insulin release examine whether extra insulin release GLP-1 allow rapidly inactivate .</brief_summary>
	<brief_title>Dipeptidyl Peptidase-4 Inhibition Glucagon-like Peptide-1 ( GLP-1 )</brief_title>
	<detailed_description>The purpose present proposal 1 ) examine role DPP-4 inhibition insulin release hyperglycemic clamp GLP-1 infuse , 2 ) elucidate role metabolite GLP-1 , GLP-1 9-36 amide ( GLP-1m ) . During stable reproducible elevate plasma glucose level effect increase active incretin level DPP-4 inhibitor result increase plasma insulin level . Therefore aim protocol document whether plasma insulin level increase follow GLP-1 infusion presence absence DPP-4 inhibitor . Additionally , show improvement glucose homeostasis GLP-1 administration due part metabolite GLP-1 , i.e . GLP-1 ( 9-36 ) amide ( GLP-1m ) . Therefore , also test role latter infuse GLP-1m volunteer treat DPP-4 inhibitor .</detailed_description>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Hct level least 34 % woman 36 % men Women nonbearing potential woman childbearing potential use adequate contraception Serum creatine level le 1.7 mg/dl Four group : Age 2145 ( BMI 18.5024.99 ) &amp; ( BMI 3035 ) Age great 65 year ( BMI 18.5024.99 ) &amp; ( BMI 3035 ) Pregnant and/or lactate female Women childbearing potential willing use adequate contraception Hct inclusion criterion Serum creatine level great 1.8 mg/dl Age le 21 age 4664 Diabetes mellitus BMI le 18 BMI great 35</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>GLP-1</keyword>
	<keyword>Januvia</keyword>
	<keyword>Sitagliptin</keyword>
</DOC>